Adherium Limited Stock

Equities

ADR

AU000000ADR1

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 02:10:45 2024-04-19 am EDT 5-day change 1st Jan Change
0.029 AUD +3.57% Intraday chart for Adherium Limited -27.50% -48.21%

Financials

Sales 2024 * 12.95M 7.62M 11.88M Sales 2025 * 31.13M 18.32M 28.54M Capitalization 10.74M 6.32M 9.85M
Net income 2024 * -1M -589K -917K Net income 2025 * 6M 3.53M 5.5M EV / Sales 2024 * 0.83 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 0.35 x
P/E ratio 2024 *
-0.07 x
P/E ratio 2025 *
0.02 x
Employees 40
Yield 2024 *
-
Yield 2025 *
-
Free-Float 67.79%
More Fundamentals * Assessed data
Dynamic Chart
1 day+3.57%
1 week-27.50%
Current month-30.95%
1 month-29.27%
3 months-52.46%
6 months-51.67%
Current year-48.21%
More quotes
1 week
0.03
Extreme 0.028
0.09
1 month
0.03
Extreme 0.028
0.09
Current year
0.03
Extreme 0.028
0.09
1 year
0.03
Extreme 0.025
0.09
3 years
0.03
Extreme 0.025
0.45
5 years
0.03
Extreme 0.025
0.96
10 years
0.03
Extreme 0.025
10.80
More quotes
Managers TitleAgeSince
Director of Finance/CFO - 22-10-09
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 20-08-02
Members of the board TitleAgeSince
Director/Board Member 75 15-04-16
Director/Board Member 61 15-12-16
Director/Board Member 66 15-07-19
More insiders
Date Price Change Volume
24-04-19 0.029 +3.57% 4 610 991
24-04-18 0.028 -9.68% 2,097,747
24-04-17 0.031 -3.13% 8,783,011
24-04-16 0.032 -15.79% 13,167,200
24-04-15 0.038 -5.00% 60,620,880

Delayed Quote Australian S.E., April 19, 2024 at 02:10 am EDT

More quotes
Adherium Limited is a New Zealand-based international respiratory e-health company. The Company is focused on patient medication adherence, remote monitoring and data management solutions for patients, payers and providers. The Company’s Hailie sensor technology and cloud-based data platform provides real-time feedback on patients' use of inhaled medication, enabling optimal management of difficult-to-treat and severe asthma and chronic obstructive pulmonary disease (COPD), and reduces direct and indirect healthcare costs. The Company’s technologies include The Hailie Remote Patient Management (RPM) Solution, The Hailie Sensors and The Hailie Solution. Its Hailie solution is a cloud-based platform, which captures medication use data from Food and Drug Administration (FDA)-cleared Bluetooth enabled sensors, which wrap around patient inhalers and provide real-time feedback to patients via the Hailie application and to their physicians via the Hailie portal.
More about the company

Annual profits - Rate of surprise